文献速递心血管外周血管技术与安全PETSPECT

定量心血管分子影像的临床价值:迈向精准医学的一步

The clinical value of quantitative cardiovascular molecular imaging: a step towards precision medicine.
PubMed 文献 · Br J Radiol · 2023-10-24

综述指出心血管疾病是全球首位死因,精准医学可为该类患者带来显著健康获益。分子影像能在解剖影像之外评估个体生物学过程,SPECT与PET系统的新发展结合新型特异性放射性药物,可提高诊断准确性并改善疗效评估。综述还讨论了定量PET与SPECT在动脉粥样硬化、心肌灌注与缺血、浸润性心肌病、系统性血管疾病及感染性心血管疾病中的临床价值,并指出临床转化仍缓慢、面临诸多挑战。

要点

  • 分子影像可在解剖影像之外评估个体生物学过程,可能成为心血管疾病精准医学实施的关键。
  • SPECT与PET系统的新发展结合快速创新的特异性放射性药物,显著提高了诊断准确性和疗效评估。
  • 近期技术进展使精准图像定量、动态成像和放射性示踪剂动力学定量成为可能,有助于评估疾病活动度和治疗反应。

核心结论

  • 分子影像结合定量PET与SPECT在心血管疾病多个领域具有临床价值,可能改善患者健康结局并减少社会影响,但临床转化仍缓慢。

研究设计与样本

  • 综述,描述分子影像及定量PET与SPECT在心血管分子影像各领域的最新进展、临床价值、临床转化挑战和未来方向。

临床应用与阅片要点

  • 综述指出分子影像可评估动脉粥样硬化、心肌灌注与缺血、浸润性心肌病、系统性血管疾病及感染性心血管疾病等领域的生物学过程。
  • 定量PET与SPECT结合动态成像和放射性示踪剂动力学定量,可能有助于更好地评估疾病活动度变化和治疗反应监测。
  • 综述指出这些新方法的临床转化仍然缓慢,并讨论了需要克服的挑战。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Cardiovascular diseases (CVD) are the leading cause of death worldwide and have an increasing impact on society. Precision medicine, in which optimal care is identified for an individual or a group of individuals rather than for the average population, might provide significant health benefits for this patient group and decrease CVD morbidity and mortality. Molecular imaging provides the opportunity to assess biological processes in individuals in addition to anatomical context provided by other imaging modalities and could prove to be essential in the implementation of precision medicine in CVD. New developments in single-photon emission computed tomography (SPECT) and positron emission tomography (PET) systems, combined with rapid innovations in promising and specific radiopharmaceuticals, provide an impressive improvement of diagnostic accuracy and therapy evaluation. This may result in improved health outcomes in CVD patients, thereby reducing societal impact. Furthermore, recent technical advances have led to new possibilities for accurate image quantification, dynamic imaging, and quantification of radiotracer kinetics. This potentially allows for better evaluation of disease activity over time and treatment response monitoring. However, the clinical implementation of these new methods has been slow. This review describes the recent advances in molecular imaging and the clinical value of quantitative PET and SPECT in various fields in cardiovascular molecular imaging, such as atherosclerosis, myocardial perfusion and ischemia, infiltrative cardiomyopathies, systemic vascular diseases, and infectious cardiovascular diseases. Moreover, the challenges that need to be overcome to achieve clinical translation are addressed, and future directions are provided.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Tingen HSA, van Praagh GD, Nienhuis PH, et al. The clinical value of quantitative cardiovascular molecular imaging: a step towards precision medicine. Br J Radiol. 2023. PMID: 37786997. doi:10.1259/bjr.20230704

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。